CVS Health Corp (NYSE:CVS) concluded the trading at $56.31 on Wednesday, May 01, with a fall of -16.84% from its closing price on previous day.
Taking a look at stock we notice that its last check on previous day was $67.71 and 5Y monthly beta was reading 0.51. Company’s P/E ratio for the trailing 12 months is 8.71. Considering stock’s 52-week price range provides that CVS hit a high price of $83.25 and saw its price falling to a low level of $64.41 during that period. Over a period of past 1-month, stock came subtracting -23.72% in its value.
With its current market valuation of $70.86 billion, CVS Health Corp is set to declare its quarterly results on May 01, 2024. CVS Stock’s Forward Dividend of 2.54 and its yield of 4.51% are making investors’ thoughts stronger that it could climb further before the company announces its earnings for the current quarter. Analysts are in estimates of 1.69 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to 8.28 for current year with estimates of that growing to 9.14 in next year.
Analysts watching the company’s growth closely have provided estimates for its revenue growth with an average revenue estimate of 89.21B. They suggested that in the process company could generate revenue of as low as 87.42B which could climb up to 91.18B to hit a high. The average estimate is representing an increase of 10.40% in sales growth from that of posted by the company in the same quarter of last year. In keeping analyst consensus estimate with, company is forecasted to be making an annual revenue of 370.93B in current fiscal year, which will be 3.70% more from revenue generated by the company last year.
In contrast, when we review CVS stock’s current outlook then short term indicators are assigning it an average of 100% Sell, while medium term indicators are categorizing the stock at an average of Hold. Long term indicators are suggesting an average of 50% Sell for it.
Digging deeper we become aware of the PEG ratio of the CVS stock which is currently positioned at 2.36. It further provides that stock’s current price level is -19.66% away from its 20-day simple moving average and is -23.89% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 12.86 while volatility remained at 2.15% over the past week which changes to 2.08% when measuring it over the past month. Beta is valued at 0.57, while measure of average true range or ATR is currently at 2.31.
Having a second look at CVS Health Corp (NYSE:CVS) provides that stock’s average daily trading volume for 3 months was 10.31 million. Number of outstanding shares of the stock stood at 1.29 billion.
The percentage of outstanding shares held by the insiders is 0.17% while it is 81.97% for the institutional holders. Subtraction of -28.69% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.
